Replies to post #398356 on Amarin Corp Plc (AMRN)

[Number sleven]

Pdude, Outstanding. These people probably eat good cheese straight out of the refrigerator. I will not be voting for Denner. Not for full control of the board.
Sleven,

[Nukemtiltheyglow]

Yeah whatever. See you in a couple months, thank god.

[rafunrafun]

$AMRN 95% vs 5%

As a shareholder of $AMRN, which team would you choose? #Vascepa

— Raf 🍊 (@ra_fun) January 11, 2023

Yeah, KM is doing fantastic. When he became CEO on August 1, 2021, PPS was $6.50 & it dropped by a whopping 82% to $1.20, until Denner made his announcement last week.

The scripts are looking fantastic, y/y have been dropping by over 20% consistently & are being beaten by Lovaza.

Sales from ex-USA are on fire.

Approvals in Spain, Germany & China were marvelous.

Their social media game is awesome.

Biological differences of V & gV were made known to the world.

But other than all that, the management has done a great job. We have so much to look forward to with these guys.

[wikthor]

Exactly, right now to sit and wait. Thank you very much Pdude for your contributions.
I think she is putting too much passion and little head. Of people besides that today everything is to the moon to pass to the hell.

Comment, that I've been quoted, that the peak sales to which I refer, is NEVER that of AMRN. It's the mathematical estimate that these BP make through what it achieves in the 1st, 2nd round of reimbursements. They've entire departments calculating margins, expansion, r&d or how much debt rises for every $ invested in marketing or lobbying.
If AMRN sells $1,500M, BP pays x5, it doesn't expect back those other 5 years (at least) of patent for those sales. She counts as PFE in Canada in highly calculated % each month until she reaches her goal. And in addition to the R&D of the IPE, I think there is a lot of room for applications, MITIGATE, half dose, combo pill and new patents. Cash, NO debt.

China. They'll never pay the €170 in EU. NEVER. But this market isn't the price, it's HIGH volume.
Nothing indicates that you cannot reach the 10% of the population that takes statins as the main market.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827089/
https://www.scienceopen.com/document_file/f159c6cb-246f-403b-b5e2-001bc765940b/API/CVIA.2016.0051.pdf

In fact here I believe it is very important to have authorized the least amount of IPE for the same (or similar effect) at the cost level.

In this:
Seven million French patients take statins, often for longer periods than they do in other countries, at a cost of €2bn a year to the state.
In China it means 140 MILLION possible patients if it continues the development of its middle class, cities, worse nutrition... Even if it was only a quarter.

THIS is the HUGE market.


We are ALL in the same boat, more head and less heart.

[Jasbg]

Pdude,

The only thing anyone has said Denner is going to do is “raise the SP and sell the company”. No shit but that is not a business plan that signifies any real change to what THE NEW F$$KING BOARD AND NEW MANAGEMENT are doing.

The new Board might stop stealing Millions of shares (with options for millions more) from an already suffering Company - putting them into their private accounts.

You are impressed by a new CEO - that in 8 months lost more than 80% of value of Company. Amarin revenue - his first Quarter fell 30% - were what WS reacted to - and sent the SP back to little above $1 - where it has stayed for months and months - until Denner announces calling the Special meeting.

Expert on Europe MA - Germany an absolute disaster - almost a year lost in time + around $100 million cash. Know there is Covid and other explanations - but many BIO companies at the same time had the time of their life - could it have maybe something to do with leadership and management ?
------------------------------------------------

What KM should have done (had he had the balls) were to day one in office announce 3 simple things for New Direction of Company:

1. No more F4 bonuses for anyone - until Company back on secure growth track.

2. No more GIA plans for the future. The goal for Amarin is to be sold (BO) soon as possible.

3. Only BP has the power and resources to handle Europe - where the process of getting to the marked, in reality is times 27(28) of the same process getting into US marked. Power of BP equally needed for getting to ROW in time.
--------------------------------------------

Basically what KM should have done when he took over - is what Denner is going to announce when he hopefully soon 'clean house' - and announce - no more F4 - no more GIA - Amarin for Sale.

All rather simple to understand really :)

[oneragman]

Pdude, I started running a business at 19 years old. $3M+ in sales back in 1981. Became 3rd largest in the country in my segment, so I am all about facts and reality. KM did not immediately cut the sales force or ads. That $90M first quarter loss is on him. Only after that which coincidentally was also only after Denner took a position did he do something. Germany...if he is such an expert, he should have known how it could play out. Never mentioned it while attempting to launch. After failing and wasting $4M, he states how tough Germany is and that many drugs fail to get proper approval. So he knew the history, never talked about it prior to launch, went all in and failed. I call that misleading to shareholders at best and wreckless at worse. All I know and all I need to know about Denner is he will get the share price up and sell for as much as he can get, which is far better than where we presently are. As an independent company, AMRN will never see double digits again unless it's because of a buyout. If they had a pipeline, they could. If they try to aquire one, they will dilute us to oblivion. They don't have the money to start any new clinical trials. Presently they do have money to pay themselves. Sales for 2023 will be less than 2022, even when you include the EU. Did they mention EU sales when they mentioned being cashflow positive? No, that because they suck. So excuse me if I take my 40+ years of running a global business over your opinion which isn't supported by facts.

[Meowza]

But blah blah happened on KM's watch!

Kidding aside, sorry to see you taking a break, understand why you're doing, hope my shenanigans helped take the edge off, and look forward to your return.